Skip to content

A follow-up of coagulation function and inflammatory response in sterilized women

A follow-up of coagulation function and inflammatory response in sterilized women

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099975
Enrollment
Unknown
Registered
2025-04-01
Start date
2025-04-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Silver clip group (Experimental group):None
Sterilization group (control group):None
Tool contraceptive group (cntrol group):None

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria for the Experimental Group: 1. Aged 40-70 years old, who have undergone silver clip sterilization in the past, and intend to undergo surgical treatment due to benign gynecological diseases (surgical resection includes bilateral fallopian tubes); 2. Long-term residence in the place of origin after sterilization; 3. Agree and be able to follow planned study visits, treatment protocols, laboratory tests, and other study procedures. Inclusion Criteria for the Control Group: Inclusion Criteria for Ligation Control Group: 1. Females who have undergone sterilization in the past; The age difference between the patients in the experimental group and the experimental group was less than 10; 2. Live in the same county as the patients in the experimental group; 3. The operation time was within 1 month after surgery for the patients in the experimental group. The remaining criteria were the same as those in the experimental group. Inclusion Criteria for the Instrumental Contraceptive Group: 1. Women who take contraception with tools; The remaining criteria were the same as those in the experimental group.

Exclusion criteria

Exclusion criteria: Exclusion criteria of the experimental group: 1. those who have undergone abdorminal procedure (include ceserean section with sterilization) 2. those who have previously undergone other metal implants (such as esophageal pacemaker implantation, heart valve replacement, fracture metal material fixing, metal sutures or clipsetc); 3. those whose workplaces are contaminated with heavy metals; 4. those who reside 20 km or less from a factory contaminated with heavy metals; 5. those who have a history of utilizing silver utensils, long-term use of silver jewelry, hair dye, or makeup; 6. those who currently have or had a serious pelvic and abdominal infection in the past ; 7. People who, in the researchers' opinion, are unsuitable for participation in this study. Exclusion criteria for the control group: the same as the exclusion criteria for the experimental group.

Design outcomes

Primary

MeasureTime frame
Cytokines (tumor necrosis factor-a, interleukin 1-ß, interleukin 6, interleukin 8, interleukin 10);Coagulation function;Tissue factor, tissue factor pathway inhibitor;

Secondary

MeasureTime frame
Fallopian tube epithelial cells (number density, volume density, surface area density, and scanning electron spectroscopy of organelles);Pelvic Adhesion Score;

Countries

China

Contacts

Public ContactLijuan Zhang

The Second Hospital of Hebei Medical University

lijuan35@sina.com+86 135 0321 2131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026